Well, we do all understand the crux of that--achieving significant price levels will be largely based on the products they deliver to market. The problem at this juncture, in pennyland as a startup biotech is that they are very vulnerable to the hazing like torments while some entities and wannabe high rollers capitalize quite handsomely off such.

Never underestimate the power of word-of-mouth. Especially where most can sit behind their computers and be the evil Plankton's of the underworld, earning $$$ to cause hardship, anonymously.

That is where they are now. And I see you will probably never be convinced that forums and public sentiment have a lot to do with pps when you are still in development. I think I understand why, too. But. you are very much mistaken.

Here's hoping for a great BMSN week along with a website update. Hell, a makeover would be nice! How beneficial that would be.